Eli Lilly to buy bowel disease drug developer Morphic for $3.2bn
![](https://4gi.tv/wp-content/uploads/2024/07/0907-ws-he1-1024x576.jpg)
Eli Lilly to acquire Morphic Holding companies said Monday that for $3.2 billion in cash, they will give the U.S. drugmaker access to an experimental drug to treat various inflammatory bowel diseases.
POPULAR POSTS
![](https://4gi.tv/wp-content/uploads/2024/09/0609-ws-env2.jpg)
Pope Francis calls for action on climate change
September 6, 2024
![](https://4gi.tv/wp-content/uploads/2024/09/0609-ws-env1.jpg)
Climate change costing Africa up to 5% of GDP, UN says
September 6, 2024
![](https://4gi.tv/wp-content/uploads/2024/09/0609-ws-env.jpg)
A forest fire has destroyed 20% of the forests in Brazil
September 6, 2024
![](https://4gi.tv/wp-content/uploads/2024/09/0609-ws-cul2.jpg)
Toronto Film Festival showcases an industry transformed by streaming
September 6, 2024
LIVE STREAM